Topiramate
CAS No. 97240-79-4
Topiramate( McN 4853 | RWJ 17021 | TPM )
Catalog No. M16879 CAS No. 97240-79-4
Topiramate (brand name Topamax) is an anticonvulsant drug produced by Ortho-McNeil Neurologics.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 34 | In Stock |
|
| 50MG | 45 | In Stock |
|
| 100MG | 59 | In Stock |
|
| 200MG | 101 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTopiramate
-
NoteResearch use only, not for human use.
-
Brief DescriptionTopiramate (brand name Topamax) is an anticonvulsant drug produced by Ortho-McNeil Neurologics.
-
DescriptionTopiramate (brand name Topamax) is an anticonvulsant drug produced by Ortho-McNeil Neurologics, a division of Johnson & Johnson. It is used to treat epilepsy in both children and adults. In children it is also indicated for treatment of Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delays). It is also Food and Drug Administration (FDA) approved for, and now most frequently prescribed for, the prevention of migraines. A combination product containing phentermine and topiramate extended-release called QSYMIA is indicated for the management of obesity. (In Vitro):Topiramate has been believed to be a type of antiepileptic drug that blocks spread of seizures. Thus far, the mechanisms of its actions have been proven to include use-dependent inhibition of voltage-dependent Na+ channels in neurons, potentiation of GABA (γ-amino-butyric acid)-induced Cl- influx, and inhibitory effects on inward currents by antagonizing kainate/alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors.
-
In VitroTopiramate has been believed to be a type of antiepileptic drug that blocks spread of seizures. Thus far, the mechanisms of its actions have been proven to include use-dependent inhibition of voltage-dependent Na+ channels in neurons, potentiation of GABA (γ-amino-butyric acid)-induced Cl- influx, and inhibitory effects on inward currents by antagonizing kainate/alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors.
-
In Vivo——
-
SynonymsMcN 4853 | RWJ 17021 | TPM
-
PathwayMembrane Transporter/Ion Channel
-
TargetCarbonic Anhydrase
-
RecptorCarbonic anhydrase| GABAR| mGluR5
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number97240-79-4
-
Formula Weight339.36
-
Molecular FormulaC12H21NO8S
-
Purity>98% (HPLC)
-
SolubilityEthanol: 68 mg/mL (200.37 mM); DMSO: 68 mg/mL (200.37 mM)
-
SMILESCC1(O[C@H]([C@@H](CO[C@@]2(COS(=O)(N)=O)O3)O1)[C@@H]2OC3(C)C)C
-
Chemical Name((3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl sulfamate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nowakowska E, et al. Arzneimittelforschung. 2009;59(10):487-92.
molnova catalog
related products
-
Compound CDy9
Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.
-
Tioxolone
Tioxolone is a metalloenzyme carbonic anhydrase I inhibitor.
-
Histone acetyltransf...
Histone acetyltransferase p300 Inhibitor 4c is a 2-aminothiazole derivative. Histone acetyltransferase p300 Inhibitor 4c inhibited hCA I, hCA II, AChE and BChE with Ki values of 0.008 ± 0.001, 0.124 ± 0.017, 0.129 ± 0.030 and 0.083 ± 0.041 μM. 0.017, 0.129 ± 0.030 and 0.083 ± 0.041 μM.
Cart
sales@molnova.com